Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T20:34:37.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T20:08:46.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The two screenshots show only layout/UI adjustments with no changes to the study details or key data.
    Difference
    0.0%
    Check dated 2026-03-04T14:16:43.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    - No substantive content changes detected; core study information remains the same, with only layout and visual adjustments visible in the screenshots.
    Difference
    0.0%
    Check dated 2026-02-25T10:34:43.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the study conditions, and the Genetic and Rare Diseases Information Center resource was added.
    Difference
    0.1%
    Check dated 2026-02-18T07:37:44.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the prior government-funding lapse notice (Revision: v3.4.1); no study data, eligibility criteria, or core page content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:00:19.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.